New Key Statistics Module, Z-Score and F-Score
NAS:TLIS Key Ratios
| Market Cap $ M | 16.67 |
| Enterprise Value $ M | -40.39 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.24 |
| Price/Sales | 40.13 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -34.18 |
| Beneish M-Score | -5.13 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 18.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.60 |
| EV-to-EBITDA | 0.61 |
| PEG | -- |
| Shares Outstanding M | 1.82 |
| Net Margin (%) | -15,050.24 |
| Operating Margin % | -16,217.23 |
| Pre-tax Margin (%) | -15,050.24 |
| Quick Ratio | 8.86 |
| Current Ratio | 8.86 |
| ROA % (ttm) | -49.42 |
| ROE % (ttm) | -64.10 |
| ROIC % (ttm) | -237.69 |
| Dividend Yield % | -- |
| Altman Z-Score | -8.88 |
TLIS Number of Guru Trades
TLIS Volume of Guru Trades
Gurus Latest Trades with NAS:TLIS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TLIS is held by these investors
Total 1
Talis Biomedical Corp Insider Transactions
No Available Data
News about NAS:TLIS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers